Equity Overview
Price & Market Data
Price: $2.11
Daily Change: -$0.03 / 1.42%
Range: $2.07 - $2.23
Market Cap: $12,426,887
Volume: 98,174
Performance Metrics
1 Week: -10.59%
1 Month: -29.67%
3 Months: -37.20%
6 Months: -47.38%
1 Year: -8.26%
YTD: -50.82%
Company Details
Employees: 109
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.